1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Hemostatic Powders Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Medical Hemostatic Powders by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Medical Hemostatic Powders by Country/Region, 2018, 2022 & 2029
2.2 Medical Hemostatic Powders Segment by Type
2.2.1 Polysaccharide Type
2.2.2 Cellulose Type
2.2.3 Gelatin Type
2.2.4 Others
2.3 Medical Hemostatic Powders Sales by Type
2.3.1 Global Medical Hemostatic Powders Sales Market Share by Type (2018-2023)
2.3.2 Global Medical Hemostatic Powders Revenue and Market Share by Type (2018-2023)
2.3.3 Global Medical Hemostatic Powders Sale Price by Type (2018-2023)
2.4 Medical Hemostatic Powders Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Medical Hemostatic Powders Sales by Application
2.5.1 Global Medical Hemostatic Powders Sale Market Share by Application (2018-2023)
2.5.2 Global Medical Hemostatic Powders Revenue and Market Share by Application (2018-2023)
2.5.3 Global Medical Hemostatic Powders Sale Price by Application (2018-2023)
3 Global Medical Hemostatic Powders by Company
3.1 Global Medical Hemostatic Powders Breakdown Data by Company
3.1.1 Global Medical Hemostatic Powders Annual Sales by Company (2018-2023)
3.1.2 Global Medical Hemostatic Powders Sales Market Share by Company (2018-2023)
3.2 Global Medical Hemostatic Powders Annual Revenue by Company (2018-2023)
3.2.1 Global Medical Hemostatic Powders Revenue by Company (2018-2023)
3.2.2 Global Medical Hemostatic Powders Revenue Market Share by Company (2018-2023)
3.3 Global Medical Hemostatic Powders Sale Price by Company
3.4 Key Manufacturers Medical Hemostatic Powders Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Hemostatic Powders Product Location Distribution
3.4.2 Players Medical Hemostatic Powders Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Hemostatic Powders by Geographic Region
4.1 World Historic Medical Hemostatic Powders Market Size by Geographic Region (2018-2023)
4.1.1 Global Medical Hemostatic Powders Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Medical Hemostatic Powders Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical Hemostatic Powders Market Size by Country/Region (2018-2023)
4.2.1 Global Medical Hemostatic Powders Annual Sales by Country/Region (2018-2023)
4.2.2 Global Medical Hemostatic Powders Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical Hemostatic Powders Sales Growth
4.4 APAC Medical Hemostatic Powders Sales Growth
4.5 Europe Medical Hemostatic Powders Sales Growth
4.6 Middle East & Africa Medical Hemostatic Powders Sales Growth
5 Americas
5.1 Americas Medical Hemostatic Powders Sales by Country
5.1.1 Americas Medical Hemostatic Powders Sales by Country (2018-2023)
5.1.2 Americas Medical Hemostatic Powders Revenue by Country (2018-2023)
5.2 Americas Medical Hemostatic Powders Sales by Type
5.3 Americas Medical Hemostatic Powders Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Hemostatic Powders Sales by Region
6.1.1 APAC Medical Hemostatic Powders Sales by Region (2018-2023)
6.1.2 APAC Medical Hemostatic Powders Revenue by Region (2018-2023)
6.2 APAC Medical Hemostatic Powders Sales by Type
6.3 APAC Medical Hemostatic Powders Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Hemostatic Powders by Country
7.1.1 Europe Medical Hemostatic Powders Sales by Country (2018-2023)
7.1.2 Europe Medical Hemostatic Powders Revenue by Country (2018-2023)
7.2 Europe Medical Hemostatic Powders Sales by Type
7.3 Europe Medical Hemostatic Powders Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Hemostatic Powders by Country
8.1.1 Middle East & Africa Medical Hemostatic Powders Sales by Country (2018-2023)
8.1.2 Middle East & Africa Medical Hemostatic Powders Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical Hemostatic Powders Sales by Type
8.3 Middle East & Africa Medical Hemostatic Powders Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Hemostatic Powders
10.3 Manufacturing Process Analysis of Medical Hemostatic Powders
10.4 Industry Chain Structure of Medical Hemostatic Powders
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Hemostatic Powders Distributors
11.3 Medical Hemostatic Powders Customer
12 World Forecast Review for Medical Hemostatic Powders by Geographic Region
12.1 Global Medical Hemostatic Powders Market Size Forecast by Region
12.1.1 Global Medical Hemostatic Powders Forecast by Region (2024-2029)
12.1.2 Global Medical Hemostatic Powders Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Hemostatic Powders Forecast by Type
12.7 Global Medical Hemostatic Powders Forecast by Application
13 Key Players Analysis
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Medical Hemostatic Powders Product Portfolios and Specifications
13.1.3 BD Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Medical Hemostatic Powders Product Portfolios and Specifications
13.2.3 Johnson & Johnson Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Qingdao Zhonghui Health Industrial Group
13.3.1 Qingdao Zhonghui Health Industrial Group Company Information
13.3.2 Qingdao Zhonghui Health Industrial Group Medical Hemostatic Powders Product Portfolios and Specifications
13.3.3 Qingdao Zhonghui Health Industrial Group Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Qingdao Zhonghui Health Industrial Group Main Business Overview
13.3.5 Qingdao Zhonghui Health Industrial Group Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Medical Hemostatic Powders Product Portfolios and Specifications
13.4.3 Pfizer Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Success Bio-Tech
13.5.1 Success Bio-Tech Company Information
13.5.2 Success Bio-Tech Medical Hemostatic Powders Product Portfolios and Specifications
13.5.3 Success Bio-Tech Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Success Bio-Tech Main Business Overview
13.5.5 Success Bio-Tech Latest Developments
13.6 Hangzhou Singclean Medical Products
13.6.1 Hangzhou Singclean Medical Products Company Information
13.6.2 Hangzhou Singclean Medical Products Medical Hemostatic Powders Product Portfolios and Specifications
13.6.3 Hangzhou Singclean Medical Products Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hangzhou Singclean Medical Products Main Business Overview
13.6.5 Hangzhou Singclean Medical Products Latest Developments
13.7 Medtrade Products
13.7.1 Medtrade Products Company Information
13.7.2 Medtrade Products Medical Hemostatic Powders Product Portfolios and Specifications
13.7.3 Medtrade Products Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Medtrade Products Main Business Overview
13.7.5 Medtrade Products Latest Developments
13.8 Beijing Tech-Bio-Med Medical Equipment
13.8.1 Beijing Tech-Bio-Med Medical Equipment Company Information
13.8.2 Beijing Tech-Bio-Med Medical Equipment Medical Hemostatic Powders Product Portfolios and Specifications
13.8.3 Beijing Tech-Bio-Med Medical Equipment Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Beijing Tech-Bio-Med Medical Equipment Main Business Overview
13.8.5 Beijing Tech-Bio-Med Medical Equipment Latest Developments
13.9 Baxter (PerClot)
13.9.1 Baxter (PerClot) Company Information
13.9.2 Baxter (PerClot) Medical Hemostatic Powders Product Portfolios and Specifications
13.9.3 Baxter (PerClot) Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Baxter (PerClot) Main Business Overview
13.9.5 Baxter (PerClot) Latest Developments
13.10 BioCer Entwicklungs
13.10.1 BioCer Entwicklungs Company Information
13.10.2 BioCer Entwicklungs Medical Hemostatic Powders Product Portfolios and Specifications
13.10.3 BioCer Entwicklungs Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BioCer Entwicklungs Main Business Overview
13.10.5 BioCer Entwicklungs Latest Developments
13.11 Hemostasis
13.11.1 Hemostasis Company Information
13.11.2 Hemostasis Medical Hemostatic Powders Product Portfolios and Specifications
13.11.3 Hemostasis Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hemostasis Main Business Overview
13.11.5 Hemostasis Latest Developments
13.12 Qingdao Biotemed Biomaterials
13.12.1 Qingdao Biotemed Biomaterials Company Information
13.12.2 Qingdao Biotemed Biomaterials Medical Hemostatic Powders Product Portfolios and Specifications
13.12.3 Qingdao Biotemed Biomaterials Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Qingdao Biotemed Biomaterials Main Business Overview
13.12.5 Qingdao Biotemed Biomaterials Latest Developments
13.13 Aegis Lifesciences
13.13.1 Aegis Lifesciences Company Information
13.13.2 Aegis Lifesciences Medical Hemostatic Powders Product Portfolios and Specifications
13.13.3 Aegis Lifesciences Medical Hemostatic Powders Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Aegis Lifesciences Main Business Overview
13.13.5 Aegis Lifesciences Latest Developments
14 Research Findings and Conclusion
| ※参考情報 医療用止血粉末は、出血を抑えるために使用される特別な粉末であり、外傷や手術中の出血を迅速に止めるために用いられます。止血は外科手術における重要なプロセスであり、出血が多量に生じると、患者の生命にかかわる問題になるため、止血材料の役割は非常に重要です。 医療用止血粉末の基本的な定義は、血液の凝固プロセスを促進する物質または材料のことを指します。これらは、血液中の血小板やフィブリン（血液凝固の核となる成分）と相互作用し、出血を効果的に制御します。粉末状になっていることで、局所的に適用しやすく、出血のある部位に対して直接的な圧力を加えることが可能となります。 特徴としては、医療用止血粉末は多くの場合、生物由来の成分を含んでいます。これにはコラーゲン、ゼラチン、セルロースなどが含まれることが多く、これらは身体に優しく、アレルギー反応のリスクを低減します。また、止血粉末は使用後に体内で分解され、通常の代謝機構によって排除されるため、外科手術後の合併症のリスクを最小限に抑えることができます。 種類については、いくつかの異なるタイプの医療用止血粉末が存在します。一般的には、物理的な圧迫作用によって止血するもの、化学的な方法で凝固を促進するもの、そして生物学的成分を利用して止血するものに分けられます。物理的なタイプとしては、ゼラチンやコラーゲンを基にしたものがあります。これらは出血箇所に粘着性を持ち、血液と結合することで、一時的に止血を実現します。化学的なタイプには、特定の凝固因子を含む粉末があり、これらの因子が直接的に血液凝固メカニズムに作用します。生物学的成分を使用した止血粉末は、自然の材料を使って血液の止まりやすさを向上させることを目的としています。 用途としては、外科手術や外傷治療の現場で幅広く利用されています。特に、緊急時における迅速な止血が求められる場合に効果を発揮します。たとえば、外傷救護の現場では、救急救命士や医療スタッフが止血粉末を使用して、応急処置を行います。また、内視鏡手術や外科手術中にも、手術部位からの出血を制御するために用いられることが多いです。さらに、スポーツ医学や整形外科などでも活用され、外的な衝撃による出血を防ぐための手段として重要です。 関連技術としては、止血粉末の開発には生体材料学や薬剤学の知見が生かされています。特に、ナノテクノロジーの進展により、より効率的に止血を行うための粉末材料が開発されつつあります。これには、特定の直径や表面特性を持つナノ粒子を利用することで、血液との相互作用を最適化する研究が含まれます。また、止血粉末とともに、他の治療手段や器具との併用が考えられ、より複合的に出血制御が行える場面が増えています。 さらに、最近の研究では、止血粉末の応用範囲が広がりつつあります。たとえば、止血粉末を使用した新しい治療法や、患者の個々の状況に応じたカスタマイズが進められています。これにより、より効果的で安全な止血が期待されています。 総じて、医療用止血粉末は、急性の出血を制御するための重要な医療材料であり、多岐にわたる用途と技術を背景に、今後もその役割はますます重要になっていくと考えられます。医療現場における迅速で効果的な止血を実現するために、多様な研究や技術開発が進んでおり、それに伴い新たな製品の登場が期待されています。これにより、患者の安全性と治療効果が向上し、より良い医療サービスが提供されることに寄与するでしょう。 |
